Moyses Niremberg

https://assets.montefioreeinstein.org/profiles/images/physphoto/Niremberg_Moyses_MD_420x504.jpg

First Name

Moyses

Last Name

Niremberg

NPI

1861599698

Faculty ID

2623

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

4337

Is Open Scheduling

Off

Joel Neugarten

https://assets.montefioreeinstein.org/profiles/images/physphoto/Neugarten_Joel_MD_420x504.jpg

First Name

Joel

Last Name

Neugarten

NPI

1750466520

Faculty ID

1225

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

<p>Acute and Chronic Kidney Disease<span style="font-size:10.5pt;font-family:'Arial',sans-serif;color:#5B5B5B;"></span></p>

Research Focus

Dr. Neugarten's main research interest is investigating mechanisms of acute and chronic kidney injury

Elsevier Profile

Selected Publications

<p><ol>
<li>Neugarten J. Estrogen and oxidative stress. Gend Med. Mar;4(1):31-2. 2007.</li>
<li>Silbiger S, Neugarten J. Gender and human renal disease. Gend Med.5: Suppl A:S3-S10. Review</li>
<li>Neugarten J: Estrogen and reactive oxygen species. Gender Med. . 2008</li>
</ol></p>

EMR ID

3415

Biography

Dr. Joel Neugarten is currently Professor of Medicine at the Albert Einstein College of Medicine, Medical Director of the Bedford Park Dialysis Unit, and an Attending Nephrologist at Montefiore Medical Center in the Bronx, New York. He is a graduate of the Albert Einstein College of Medicine and the Brooklyn Law School and completed his post graduate training at Mount Sinai Medical Center in New York and at New York University Medical Center. He previously served as Site Director of the Nephrology Division of Montefiore Medical Center and as President of the New York Society of Nephrology. He is an author of over 100 peer reviewed publications and book chapters dealing with numerous aspects of Nephrology. His major research interests include factors that influence the progression of chronic kidney disease and the management of patients with chronic kidney disease.

Visit Type ID

2541

Is Open Scheduling

On

Tina M. Neade

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/7bb3fcb0-c3cc-11eb-9ea2-7374238588d1.jpg

First Name

Tina

Last Name

Neade

NPI

1538331061

Faculty ID

16814

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Chronic kidney disease, Glomerular disease, End stage renal disease, Kidney stones and Hypertension

Elsevier Profile

EMR ID

52322

Biography

Tina Neade, M.D., is an Assistant Professor of Medicine in the Division of Nephrology at Montefiore Medical Center/ Albert Einstein College of Medicine. She earned her medical degree at Albert Einstein College of Medicine, New York in 2002. She then completed her internal medicine residency at Mount Sinai Hospital in New York in 2005, followed by a nephrology fellowship at Mount Sinai Hospital in 2008. Dr Neade joined the faculty at Montefiore Medical Center in 2017. Dr. Neade is board certified in Internal Medicine and Nephrology.&nbsp;

Visit Type ID

2541

Is Open Scheduling

On

Shadi Nahvi

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/51b70380-3cad-11ec-80f7-67047826a941.jpg

First Name

Shadi

Last Name

Nahvi

NPI

1821114380

Faculty ID

9811

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Provider Type

Primary Care

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Shadi Nahvi is Professor (with tenure) in the Departments of Medicine and Psychiatry and Behavioral Sciences at the Albert Einstein College of Medicine, and directs the General Internal Medicine and Addiction Medicine Fellowship Programs.&nbsp; Her research focuses on optimizing quality of life and health outcomes among persons with substance use disorder.</p>
<p>Dr. Nahvi&rsquo;s research is grounded in nearly two decades of clinical experience as a primary care physician caring for persons with opioid and other substance use disorders. Her primary research focus is optimizing the efficacy and delivery of tobacco cessation treatments among persons with co-occurring substance use disorders. Currently, she is Principal Investigator of a NIDA R01-funded randomized, 2 x 2 factorial trial of directly observed and long-term varenicline treatment among smokers with opioid use disorder. She has also led a KL2 Career Development Award-funded, randomized, placebo-controlled pilot trial of varenicline for smoking cessation among smokers with co-morbid substance use disorder, a study of health system-level interventions to increase documentation and treatment of tobacco use among substance use disorder counselors, and a randomized trial of the efficacy of directly observed varenicline provided at a methadone clinic for promoting smoking cessation and enhancing adherence.&nbsp;</p>
<p>Dr. Nahvi graduated from the Brown University School of Medicine in 2001 and completed residency training in Primary Care Internal Medicine at Bellevue Hospital and New York University Medical Center in 2004.  She then joined the faculty in the Albert Einstein College of Medicine Division of Substance Abuse as the Medical Director of an opioid treatment program.</p>
<p>Dr. Nahvi has served on numerous national advisory committees, including serving as a member of the NY State Department of Health AIDS Institute’s Guideline Committee for the Care of Substance Users and a Steering Committee member of the NY State Department of Health AIDS Institute's Tobacco Cessation Improvement Campaign.</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

Selected Publications

<p>Selected recent publications:</p>
<p>Nahvi S, Segal KS, Litwin AH, Arnsten JH. Rationale and design of a randomized controlled trial of varenicline directly observed therapy delivered in methadone clinics. <em>Addiction Science and Clinical Practice. </em>2014, 13;9:9</p>
<p class="Normal">Nahvi S, Blackstock O, Sohler NL, Thompson D, Cunningham CO. Smoking cessation treatment among office-based buprenorphine treatment patients. <em>Journal of Substance Abuse Treatment. </em>2014, 47(2):175-9</p>
<p>Nahvi S, Ning Y, Segal KS, Richter KP, Arnsten JH. Varenicline efficacy and safety among methadone maintained smokers: A randomized placebo-controlled trial. <em>Addiction. </em>2014, 109(9):1554-63</p>
<p>Griffin J, Segal KS, Arnsten JH, Nahvi S. Barriers to telephone quitline use among methadone maintained smokers. <em>Nicotine &amp; Tobacco Research.</em> 2015,17(8):931-6</p>
<p>Batchelder AW, Peyser D, Nahvi S, Arnsten JH, Litwin AH. "Hepatitis C treatment turned me around:" Psychological and behavioral transformation related to Hepatitis C treatment. <em>Drug and Alcohol Dependence.</em> 2015, 153:66-71</p>
<p>Maradiaga J, Nahvi S, Cunningham CO, Sanchez J, Fox AD. "I kicked the hard way. I got incarcerated." Withdrawal from methadone during incarceration and subsequent aversion to medication assisted treatments. <em>Journal of Substance Abuse Treatment.</em> 2016, 62:49-54</p>
<p>Fitzgerald SA, Faseru B, Mussulman L, Howser E, Nahvi S, Goggin K, Cooperman NA, Richter KP. Improving quality of care for hospitalized smokers with HIV: Tobacco dependence treatment referral and utilization. <em>The Joint Commission Journal on Quality and Patient Safety.</em> 2016, 42(5):219-24</p>
<p>Shah PA, Cunningham CO, Blackstock OJ, Brisbane MT, Nahvi S. Use of smoking cessation methods among patients receiving office-based buprenorphine maintenance treatment. <em>Journal of Addiction Medicine.</em> 2017, 11(6):494-497</p>
<p>Adams TR, Arnsten JH, Ning Y, Nahvi S. Feasibility and preliminary effectiveness of varenicline for treating co-occurring cannabis and tobacco use. <em>Journal of Psychoactive Drugs.</em>&nbsp;2018, 50(1):12-18</p>
<p>Sohler NL, Starrels J, Khalid L, Bachhuber M, Arnsten JH, Nahvi S, Jost J, Cunningham CO. Marijuana use is associated with lower odds of prescription opioid analgesic use among HIV-infected individuals with chronic pain. <em>Substance Use and Misuse. </em>2018, 17:1-6</p>
<p>Minami H, Brinkman HR, Nahvi S, Arnsten JH, Rivera-Mindt M, Wetter DW, Litvin Bloom E, Price LH, Vieira C, Donnelly R, McClain LM, Kennedy KA, D'Aquila E, Fine M, McCarthy DE, Thomas JG, Hecht J, Brown RA. Rationale, design and pilot feasibility results of a smartphone-assisted, mindfulness-based intervention for smokers with mood disorders: Project mSMART MIND. <em>Contemporary Clinical Trials. </em>2018, 66:26-44</p>
<p>Weinberger AH, Pacek LR, Wall MM, Zvolensky MJ, Copeland J, Galea S, Nahvi S, Moeller SJ, Hasin DS, Goodwin RD. Trends in cannabis use disorder by cigarette smoking status in the United States, 2002 to 2016. <em>Drug and Alcohol Dependence.</em> 2018, 191:45-51</p>
<p>Nahvi S, Arnsten JH. Missed opportunities to test the neuropsychiatric safety--and efficacy--of varenicline among smokers with substance use disorders. <em>Drug and Alcohol Dependence. </em>2018, 185: 245-247.</p>

EMR ID

4679

Is Open Scheduling

Off

Shrivatsa Nadiger

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/2f0fff80-470c-11ec-a9e7-9bd94149ce2f.jpg

First Name

Shrivatsa

Last Name

Nadiger

NPI

1417132218

Faculty ID

15176

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

90060

Is Open Scheduling

Off

Michal L. Melamed

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/66412790-2b53-11ee-9f8d-1b267177a44e.jpg

First Name

Michal

Last Name

Melamed

NPI

1407953235

Faculty ID

10492

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Languages

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Michal Melamed is a Professor of Medicine and Epidemiology &amp; Population Health at the Albert Einstein College of Medicine. She has been the Nephrology Fellowship Program Director since 2012. After completing her undergraduate degree in Dramatic Literature at New York University <em>summa cum laude</em>, she trained at Johns Hopkins School of Medicine for medical school, Internal Medicine residency, and Nephrology fellowship. Additionally, she completed a Masters in Clinical Epidemiology from the Johns Hopkins Bloomberg School of Public Health during her fellowship.</p>
<p>She has been continuously funded by the National Institutes of Health since 2007 and her research interests include the epidemiology of chronic kidney disease and its complications, the epidemiology and health consequences of Vitamin D deficiency and metabolic acidosis. Dr. Melamed is the Principal Investigator of several NIH-funded research studies.&nbsp; She has published over 90 original publications in the medical literature and has mentored countless young investigators from high school students to junior faculty members. In 2019, she won the Distinguished Mentor Award from the American Society of Nephrology.</p>
<p>&nbsp;</p>

Research Areas

Research Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

Selected Publications

<p>Selected Publications:<br />&nbsp;<br /><strong>Melamed ML</strong>, Eustace JA, Plantinga L, Jaar BG, Fink NE, Klag MJ, Coresh J, Powe NR. Changes in Serum Calcium, Phosphate and PTH and the Risk of Death in Incident Dialysis Patients: A Longitudinal Study. Kidney Int 2006 Jul;70(2):351-7.<br />&nbsp;<br />Gupta R, Plantinga LC, Fink NE, <strong>Melamed ML</strong>, Coresh J, Fox CS, Levin NW, Powe NR. Statin use and hospitalization for sepsis in patients with chronic kidney disease. JAMA 2007 Apr 4;297(13):1455-64.<br />&nbsp;<br />Hailpern SM, <strong>Melamed ML</strong>, Cohen HW, Hostetter T.&nbsp; Moderate Chronic Kidney Disease and Cognitive Function in Adults 20-59 Years of Age (NHANES III). J Am Soc Nephrol 2007 Jul;18(7):2205-13.<br />&nbsp;<br /><strong>Melamed ML,</strong> Eustace JA, Plantinga LC, Jaar BG, Fink NE, Parekh RS, Coresh J, Yang Z, Cantor T, Powe NR. Third-Generation Parathyroid Hormone Assays and All-Cause Mortality in Incident Dialysis Patients: The CHOICE Study. Nephrol Dial Transplant. 2008 May; 23(5):1650-8.</p>
<p><strong>Melamed ML*, </strong>Muntner P*, Michos ED, Uribarri J, Weber C, Sharma J, Raggi P. Serum 25-hydroxyvitamin D Levels and the Prevalence of Peripheral Arterial Disease: Results from NHANES 2001-2004. Atheroscler Thromb Vasc Biol. 2008 Jun;28(6)1179-85.<br />&nbsp;<br /><strong>Melamed ML*, </strong>Michos ED*, Post W, Astor B. 25-Hydroxyl Vitamin D Levels and the Risk of Mortality in the General Population. Arch Intern Med. 2008 Aug 11;168(15):1629-37.<br />&nbsp;<br />Shah S, Abramowitz M, Hostetter TH, <strong>Melamed ML</strong>. Serum Bicarbonate Levels and the Progression of Kidney Disease: A Cohort Study. Am J Kidney Dis. 2009 Aug;54(2):270-7.<br />&nbsp;<br />Kumar J, Muntner P, Kaskel FJ, Hailpern SM, <strong>Melamed ML</strong>. Prevalence and Associations of 25- Hydroxyvitamin D Deficiency in Children and Adolescents in the United States: Results from NHANES 2001-2004. Pediatrics. Aug 3 2009. Electronic pages.<br />&nbsp;<br />Plantinga LC, Fink NE, Coresh J, Sozio SM, Parekh RS, <strong>Melamed ML</strong>, Powe NR, Jaar BG. Peripheral vascular disease-related procedures in dialysis patients: predictors and prognosis. Clin J Am Soc Nephrol. 2009 Oct;4 (10):1637-45.<br />&nbsp;<br />Tonelli M, Curhan G, Pfeffer M, Sacks F, Thadhani R, <strong>Melamed ML</strong>, Wiebe N, Muntner P. Relation Between Alkaline Phosphatase, Serum Phosphate, and All-Cause or Cardiovascular Mortality. Circulation. 2009 Oct. 19 Epub. 2009 Nov 3;120(18):1784-92.<br />&nbsp;<br /><strong>Melamed ML</strong>, Astor B, Michos ED, Hostetter TH, Powe NR, Muntner P. 25-Hydroxyvitamin D levels, Race and the Progression of Kidney Disease. J Am Soc Nephrol. 2009 Dec.;20(12) 2631-9.<br />&nbsp;<br />Abramowitz M, Muntner P, Coco M, Southern W, Lotwin I, Hostetter TH, <strong>Melamed ML</strong>. Serum alkaline phosphatase and phosphate and risk of mortality and hospitalization. Clin J Am Soc Nephrol. 2010 Apr 8 Epub. 2010 Jun;5(6):1064-71.<br />&nbsp;<br />Murea M, Park JK, Sharma S, Kato H, Gruenwald A, Niranjan T, Si H, Thomas DB, Pullman JM, <strong>Melamed ML</strong>, Susztak K. Expression of Notch pathway proteins correlates with albuminuria, glomerulosclerosis, and renal function. Kidney Int. 2010 June 9; 78(5):514-22.<br />&nbsp;<br /><strong>Melamed ML, </strong>Blackwell T, Neugarten J, Arnsten J, Ensrud K, Ishani A, Cummings S, Silbiger S. Raloxifene, a selective estrogen receptor modulator, is renoprotective: a post-hoc analysis. Kidney Int. 2011 Jan;79(2):241-9<br /><strong>&nbsp;</strong><br />O&rsquo; Seaghdha CM, Hwang S-J, Muntner P, <strong>Melamed ML</strong>*, Fox CS*. Serum phosphorus predicts incident Chronic Kidney Disease and End-Stage Renal Disease. Nephrol Dial Transplant 2011 Sep;26(9):2885-90. Epub 2011 Feb 3.<br />&nbsp;<br />Abramowitz MK, Hostetter TH, <strong>Melamed ML</strong>. Association of Serum Bicarbonate Levels with Gait Speed and Quadriceps Strength in Older Adults. Am J Kidney Dis 2011 Feb 25.<br />&nbsp;<br />Sharief S, Jariwala S, Kumar J, Muntner P, <strong>Melamed ML</strong>. Vitamin D levels and food and environmental allergies in the United States: Results from NHANES 2005-6. Journal of Allergy and Clinical Immunology 2011 May;127(5):1195-202. Epub 2011 Feb 16. PMID: 21329969<br />&nbsp;<br />Skversky AL, Kumar J, Abramowitz MK, Kaskel FJ, <strong>Melamed ML</strong>. Association of Glucocorticoid Use and Low 25-Hydroxyvitamin D Levels: Results from the National Health and Nutrition Examination Survey (NHANES): 2001-2006. J Clin Endocrinol Metab. 2011 Sept 28. (Epub)<br />&nbsp;<br />Michos ED, Reis JP, Post WS, Lutsey PL, Gottesman RF, Mosley TH, Sharrett AR, <strong>Melamed ML</strong>. 25-Hydroxyvitamin D deficiency is associated with fatal stroke among whites but not blacks: The NHANES III linked mortality files. Nutrition 2012 Apr; 28(4)367-71.<br />&nbsp;<br />Abramowitz MK, Hostetter TH, <strong>Melamed ML</strong>. Lower serum bicarbonate and a higher anion gap are associated with lower cardiorespiratory fitness in young adults. Kidney International. 2012 May;81(10):103342. Epub 2012 Feb 1. PMCID: PMC3340439<br />&nbsp;<br />Abramowitz MK, Hostetter TH, <strong>Melamed ML</strong>. The serum anion gap is altered in early kidney disease and associates with mortality. Kidney International. 2012 Sep;82 (6):701-9.<br />&nbsp;<br />Abramowitz MK, <strong>Melamed ML</strong>, Bauer C, Raff AC, Hostetter TH. Effects of Oral Sodium Bicarbonate in Patients with CKD. Clinical Journal of the American Society of Nephrology. 2013 Feb 7^th Epub ahead of print. 2013 May; 8(5)714-20.<br /><br /><strong>Melamed ML</strong>, Plantinga L, Shafi T, Parekh R, Meyer TW, Hostetter TH, Coresh J, Powe NR. Retained organic solutes, patient characteristics and all-cause and cardiovascular mortality in hemodialysis: results from the retained organic solutes and clinical outcomes (ROSCO) investigators. BMC Nephrol 2013 June 27;14(1)134.<br />&nbsp;<br />Milman S, Schulder-Katz M, Deluty J, Zimmerman ME, Crandall JP, Barzilai N, <strong>Melamed ML*</strong>, Atzmon G*.&nbsp; Individuals with Exceptional Longevity Manifest a Delayed Association Between Vitamin D Insufficiency and Cognitive Impairment. J Am Geriatr Soc. 2014 Jan Epub.<br />&nbsp;<br />Akchurin OM, <strong>Melamed ML</strong>, Hashim BL, Kaskel FJ, Del Rio M. Medication adherence in the transition of adolescent kidney transplant recipients to the adult care. Pediatric Transplantation. 2014 May 12 Epub. 18(5):538-48.<br />&nbsp;<br />Chen W, <strong>Melamed ML</strong>, Abramowitz MK. Serum bicarbonate and Bone Mineral Density in US Adults. Am J Kidney Dis. 2014 Aug 26 Epub. 2015 Feb;65(2):240-8.&nbsp;<br />&nbsp;<br />Sarathy H, Pramanik V, Kahn J, Abramowitz MK, Meier K, Kishore P, <strong>Melamed ML</strong>. The Effects of Short-term Vitamin D Supplementation on Glucose Metabolism in Dialysis Patients: A Systematic Review and Meta-Analysis.&nbsp; Int Urol Nephrol. 2015 Mar;47(3):537-49.&nbsp;<br />&nbsp;<br />Barry EL, Mott LA, <strong>Melamed ML,</strong> Rees JR, Ivanova A, Sandler RS, Ahnen DJ, Bresalier RS, Summers RW, Bostick RM, Baron JA. Calcium supplementation increases blood creatinine concentration in a randomized controlled trial. PLoS One. 2014. Oct 15;9(10):e108094.<br />&nbsp;<br />Calp-Inal S, Ajaimy M, <strong>Melamed ML</strong>, Savchik C, Masiakos P, Colovai A, Akalin E. The prevalence and clinical significance of C1q-binding donor-specific anti-HLA antibodies early and late after kidney transplantation.&nbsp; Kidney Int 2015 Nov 4 (Epub ahead of print)<br />&nbsp;<br />Kumar J, McDermott K, Abraham AG, Friedman LA, Johnson VL, Kaskel FJ, Furth SL, Warady BA, Portale AA, <strong>Melamed ML. </strong>Prevalence and correlates of 25-hydroxyvitamin D deficiency in the Chronic Kidney Disease in Children (CKID) cohort. Pediatr Nephrol. 2016 Jan; 31(1):121-9.</p>
<p><span style="font-size: 11.0pt; font-family: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-no-proof: yes;">Chen W, <strong>Melamed ML</strong>, Hostetter TH, Bauer C, Raff AC, Almudevar AL, Lalonde A, Messing S, Abramowitz MK. Effect of oral sodium bicarbonate on fibroblast growth factor-23 in patients with chronic kidney disease: a pilot study. <em>BMC Nephrol. </em>2016;17(1):114.</span></p>
<p><span style="text-indent: -0.25in; font-size: 11pt; font-family: Arial, sans-serif;">Shafi T, Powe NR, Meyer TW, Hwang S, Hai X, <strong>Melamed ML</strong>, Banerjee T, Coresh J, Hostetter TH. Trimethylamine N-Oxide and Cardiovascular Events in Hemodialysis Patients. <em>J Am Soc Nephrol. </em>2017 Jan;28(1):321-31.</span></p>
<p><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: 'Arial','sans-serif'; mso-bidi-font-weight: bold;">Goel N, Kwon C, Zachariah TP, Broker M, Folkert VW, Bauer C, <strong>Melamed ML</strong>. Vascular access placement in patients with chronic kidney disease stages 4 and 5 attending an inner city nephrology clinic: a cohort study and survey of providers.&nbsp; <em>BMC Nephrol</em>. 2017; 18(1):28.</span></p>
<p><span style="font-size: 11.0pt; font-family: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-weight: bold;">Buttar RS, Batra J, Kreimerman J, Aleta M, <strong>Melamed ML</strong>. Rhabdomyolysis and AKI with Atorvastatin and Sitagliptin Use in the Setting of Low 25-Hydroxyvitamin D Levels. J Gen Intern Med. 2017 Oct;32(10):1156-1159.</span></p>
<p><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: 'Arial','sans-serif'; mso-bidi-font-weight: bold;">Golestaneh L Bellin E, Southern W, <strong>Melamed ML</strong>. Discharge service as a determinant of 30-day readmission in a cohort of maintenance hemodialysis patients: a retrospective cohort study. BMC Nephrol. 2017 Dec 4;18(1):352.</span></p>
<p><strong><span style="font-size: 11.0pt; font-family: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;">Melamed ML</span></strong><span style="font-size: 11.0pt; font-family: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-weight: bold;">, Chonchol M, Gutierrez OM, Kalantar-Zadeh K, Kendrick J, Norris K, Scialla JJ, Thadhani R. The Role of Vitamin D in CKD Stages 3 to 4: Report of a Scientific Workshop Sponsored by the National Kidney Foundation. Am J Kidney Dis. 2018; 72(6)834-845.</span></p>
<p><span style="font-size: 11.0pt; font-family: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-weight: bold;">Astor BC, Djamali A, Mandelbrot DA, Parajuli S, <strong>Melamed ML</strong>. The Association of 25-hydroxyvitamin D Levels with Late Cytomegalovirus Infection in Kidney Transplant Recipients: the Wisconsin Allograft Recipient Database (WisARD). Transplantation</span> <span style="font-size: 11pt; font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">2019 Aug;103(8):1683-1688</span></p>
<p><span style="font-size: 11pt; font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"><span style="font-size: 11pt; font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Chen W, Eisenberg R, Mowrey WB, Wylie-Rosett J, Abramowitz MK, Bushinsky DA, <strong>Melamed ML</strong>.&nbsp; Association between dietary zinc intake and abdominal aortic calcification in US adults. Nephrol Dial Transplant. 2019 Jul 11.</span></span></p>
<p><span style="font-family: Arial, sans-serif; font-size: 11pt; text-indent: -0.25in;">Sochol KM, Johns TS, Buttar RS, Randhawa L, Sanchez E, Gal M, Lestrade K, Merzkani M, Abramowitz MK, Mossavar-Rahmani Y, </span><strong style="font-family: Arial, sans-serif; font-size: 11pt; text-indent: -0.25in;">Melamed ML</strong><span style="font-family: Arial, sans-serif; font-size: 11pt; text-indent: -0.25in;">. The Effects of Dairy Intake on Insulin Resistance: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Nutrients 2019; 11(9):2237.</span></p>
<p><span style="font-family: Arial, sans-serif; font-size: 11pt; text-indent: -0.25in;"><strong>Melamed ML</strong>, Horwitz EJ, Dobre MA, Abramowitz MK, Zhang L, Lo Y, Mitch WE, Hostetter TH. The Effects of Sodium Bicarbonate in Chronic Kidney Disease Stages 3 and 4: A Randomized, Placebo-Control, Multi-Center Clinical Trial. American Journal of Kidney Diseases. 2020.</span></p>
<p>&nbsp;</p>

EMR ID

4836

Is Open Scheduling

Off

Maria Y. Mazing

https://assets.montefioreeinstein.org/profiles/images/default-profile-blue.svg

First Name

Maria

Last Name

Mazing

NPI

1598877276

Faculty ID

10864

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Languages

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>My research interest is in internal medicine/hospital medicine.</p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

4934

Is Open Scheduling

Off

Franklin C. Lowe

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/1c4ff810-6315-11ee-bd4e-3d8872337956.jpg

First Name

Franklin

Last Name

Lowe

NPI

1801971270

Faculty ID

14708

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Treatment of benign and malignant disorders of the prostate.<quillbot-extension-portal></quillbot-extension-portal>

Research Focus

Urological topics<quillbot-extension-portal></quillbot-extension-portal>

Elsevier Profile

EMR ID

73230

Biography

<p>Franklin C. Lowe, MD, Professor of Urology and Vice-Chair of the Department, is also Director of Urologic Services, Jack D. Weiler Hospital. An expert in the treatment of benign and malignant disorders of the prostate, Dr. Lowe has published over 150 articles on multiple urological topics and has lectured extensively throughout the world. Prior to joining The Department of Urology at Montefiore, Dr. Lowe held faculty and leadership positions at Columbia University, Mount Sinai School of Medicine and at St. Luke&rsquo;s/ Roosevelt Hospital in Manhattan. A Graduate of Princeton University, Dr. Lowe obtained both his Medical and Masters of Public Health degrees from Columbia University College of Physicians and Surgeons. He completed his internship and residency in Surgery and Urology at The James Buchanan Brady Urological Institute of Johns Hopkins University. Dr. Lowe previously served as the Chairman of The American Urological Association&rsquo;s Alternative Medicine Committee and as a member of the BPH Guidelines Committee.</p>

Is Open Scheduling

On

Luz E. Liriano-Ward

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/ccab2620-3cad-11ec-80f7-67047826a941.jpg

First Name

Luz

Last Name

Liriano-Ward

NPI

1801020896

Faculty ID

15436

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Kidney and Pancreas Transplantation

Research Focus

Short term and long term outcomes of deceased donor kidney transplantation. Pancreas transplant outcomes on Type 2 diabetics compared to type 1 diabetics. The use of SGLT2- inhibitor in kidney transplant recipients.&nbsp;

Elsevier Profile

EMR ID

3120

Biography

Luz Liriano-Ward, MD received her MD degree at Weill Cornell Medical College. She then completed internal medicine residency at NYU Langone Medical Center, followed by 2-years of nephrology fellowship and 1 year of transplant nephrology at Mount Sinai Hospital &ndash; Icahn School of Medicine. Dr. Liriano-Ward is a UNOS certified transplant nephrologist. Dr. Liriano-Ward is board certified by the American Board of Internal Medicine and the American Board of Nephrology. Dr. Liriano-Ward is a member of the American Society of nephrology and the American Society of Transplantation. She has special interest in medical education and acts as the director for the transplant nephrology fellowship at Montefiore Medical Center. She is also the director for the medical students&rsquo; nephrology rotation at Albert Einstein College of medicine / Montefiore Medical Center. She serves in multiple committees at the local and national level, including the Transplant Nephrology Fellowship Training Accreditation Program (TNFTAP) for the American Society of Transplantation.&nbsp;

Is Open Scheduling

Off

Daniel K. Levy

https://assets.montefioreeinstein.org/profiles/images/physphoto/Levy_Daniel_MD_420x504.jpg

First Name

Daniel

Last Name

Levy

NPI

1407931280

Faculty ID

1379

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

4086

Is Open Scheduling

Off